Tci Wealth Advisors, Inc. Axonics, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$39.5 - $64.42 $5,846 - $9,534	-148 Reduced 62.71%	88 $5,000
Q1 2022 Apr 29, 2022	BUY	$43.74 - $62.76 $9,404 - $13,493	215 Added 1023.81%	236 $15,000
Q4 2021 Jan 24, 2022	SELL	$50.01 - $73.35 $4,350 - $6,381	-87 Reduced 80.56%	21 $1,000
Q3 2021 Oct 29, 2021	BUY	$59.21 - $78.66 $5,151 - $6,843	87 Added 414.29%	108 $7,000
Q2 2021 Aug 02, 2021	SELL	$51.39 - $66.9 $1,644 - $2,140	-32 Reduced 60.38%	21 $1,000
Q1 2021 Apr 29, 2021	BUY	$49.14 - $59.89 $1,572 - $1,916	32 Added 152.38%	53 $3,000
Q4 2019 Jan 27, 2020	BUY	$19.57 - $28.96 $410 - $608	21 New	21 $1,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.